Oscotec (039200) stock
KOSDAQ · Pharmaceuticals
As of Nov 16, 2:33 PM KST
- Market cap
- KRW 1.3 trillion
- As of Nov 16, 2026
- P/E
- 17.40x
- Trailing twelve months
- P/B
- 6.77x
- Latest reported equity
- P/S
- 9.40x
- Trailing twelve months
- ROE
- 38.9%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
- Market cap
- KRW 1.3 trillion
- As of Nov 16, 2026
- P/E
- 17.40x
- Trailing twelve months
- P/B
- 6.77x
- Latest reported equity
- P/S
- 9.40x
- Trailing twelve months
- ROE
- 38.9%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
17.40x
P/B
6.77x
P/S
9.40x
Earnings and dividend metrics▾
Earnings
EPS
KRW 2,003
Earnings per share
BPS
KRW 5,144
Book value per share
ROE
38.9%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned KRW 2,003 per share.
- BPS — net assets divided by the number of shares. Each share is backed by KRW 5,144 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 38.9%.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from DART financial filings: net income attributable to owners of the parent and revenue are summed over the latest four quarters, equity is the latest reported equity, and prices are KRX closing prices.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Earnings
Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| Q3 2026Consolidated · Filed Nov 13, 2026 | KRW 6.6 billion | -KRW 6.7 billion | -KRW 19.7 billion | -26.6% |
| Q2 2026Consolidated · Filed Aug 14, 2026 | KRW 52.6 billion | KRW 38.7 billion | KRW 40.8 billion | +425.6% |
| Q1 2026Consolidated · Filed May 14, 2026 | KRW 3.6 billion | -KRW 10 billion | -KRW 5 billion | +88.4% |
| Q4 2025Consolidated · Filed Mar 19, 2026 | KRW 78.9 billion | KRW 61.4 billion | KRW 64 billion | — |
| Q3 2025Consolidated · Filed Nov 12, 2025 | KRW 8.9 billion | -KRW 400 million | KRW 600 million | -69.2% |
| Q2 2025Consolidated · Filed Aug 14, 2025 | KRW 10 billion | -KRW 600 million | -KRW 2.5 billion | +544.7% |
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| FY2025Consolidated · Filed Mar 19, 2026 | KRW 99.8 billion | KRW 52.1 billion | KRW 54.4 billion | — |
| FY2024Consolidated · Filed Mar 19, 2025 | KRW 34 billion | -KRW 2.7 billion | -KRW 1.6 billion | — |
- Q3 2026 is computed as 9M 2026 minus H1 2026.
- Q2 2026 is computed as H1 2026 minus Q1 2026.
- Q4 2025 is computed as FY2025 minus 9M 2025.
- Q3 2025 is computed as 9M 2025 minus H1 2025.
- Q2 2025 is computed as H1 2025 minus Q1 2025.
Short selling and securities lending
Short sales as a share of trading value, the reported short position and the securities lending balance.
- Short-sale share
- 8.33%
- Of trading value on Nov 13, 2026
- Short-sale value
- KRW 620 million
- Previous 20-day average 7.96%
- Net short position
- 296,548 shares
- As of Nov 11, 2026 · reported with a two-trading-day lag
- Lending balance
- 3,210,901 shares
- As of Nov 13, 2026 · 8.39% of listed shares
| Date | Share | Value |
|---|---|---|
| Nov 13, 2026 | 8.33% | KRW 620 million |
| Nov 12, 2026 | 7.53% | KRW 380 million |
| Nov 11, 2026 | 4.48% | KRW 260 million |
| Nov 10, 2026 | 9.16% | KRW 520 million |
| Nov 9, 2026 | 10.14% | KRW 600 million |
| Nov 6, 2026 | 8.30% | KRW 830 million |
| Nov 5, 2026 | 5.54% | KRW 630 million |
| Nov 4, 2026 | 13.87% | KRW 1.02 billion |
| Nov 3, 2026 | 9.37% | KRW 490 million |
| Nov 2, 2026 | 11.99% | KRW 460 million |
The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.
Filings
Major filings received by DART, Korea’s regulatory filing system.
- Corporate Value-up PlanNov 5, 2026English
- Resolution to Convene a Shareholders Meeting (Extraordinary General Meeting)Oct 6, 2026 · Shareholders MeetingEnglish
- Filing of Lawsuit or Petition (Management Control Dispute)(Korean)Sep 23, 2026 · Key Risk Notice
- [Amended] Report on Major Holdings of Shares (General Form)(Korean)Sep 18, 2026 · Major Holding Report
- Report on Major Holdings of Shares (General Form)(Korean)Sep 17, 2026 · Major Holding Report
- Report on Major Holdings of Shares (Short Form)(Korean)Sep 17, 2026 · Major Holding Report
- Technology or Regulatory Approval(Korean)Sep 4, 2026
- Report on Major Holdings of Shares (General Form)(Korean)Sep 1, 2026 · Major Holding Report
Filings with a published English version open in English; the rest link to the Korean original.
Oscotec (039200) stock information
KOSDAQ
Oscotec (039200) is listed on KOSDAQ. Its market capitalization is about KRW 1.3 trillion. On trailing-twelve-month earnings the P/E ratio is 17.4, and the P/B ratio is 6.77. Return on equity is 38.9%. These figures are computed in-house from official filings and are reference information only.
Oscotec — frequently asked questions
- What is the P/E ratio of Oscotec (039200)?
- On a trailing-twelve-month basis, 039200 trades at a P/E ratio of 17.4. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Oscotec?
- 039200 has a market capitalization of about KRW 1.3 trillion. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.